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Abstract: Traditional supplements of selenium generally have a low degree of absorption and 
increased toxicity. Therefore, it is imperative to develop innovative systems as transporters of 
selenium compounds, which would raise the bioavailability of this element and allow its con-
trolled release in the organism. Nanoscale selenium has attracted a great interest as a food additive 
especially in individuals with selenium deficiency, but also as a therapeutic agent without signifi-
cant side effects in medicine. This review is focused on the incorporation of nanotechnological 
applications, in particular exploring the possibilities of a more effective way of administration, 
especially in selenium-deficient organisms. In addition, this review summarizes the survey of 
knowledge on selenium nanoparticles, their biological effects in the organism, advantages, 
absorption mechanisms, and nanotechnological applications for peroral administration.
Keywords: nanoparticles, biomedicine, drug delivery, oxidative stress, anticancer effect, 
antimicrobial activity, protective effect
Methodology of the review
To carry out this study, different databases such as Web of Science, PubMed, 
MEDLINE, and Google Scholar were employed. The findings of research studies 
(original articles, experimental studies) chosen from more than 1,000 viewed scientific 
publications were compared. The emphasis was put on original articles, while more 
than 100 review articles were not included. The search was based on phrases such 
as selenium nanoparticles and antioxidant activity/antimicrobial properties/antiviral 
effect/antibacterial activity/anticancer agent, selenium nanoparticles and synthesis, 
nano-selenium and bioavailability/toxicity/safety/drug delivery/orthopedic implants/
protective effects/oxidative stress/metal intoxication/immunomodulation/reproduction/
growth/gastrointestinal tract/hair, selenium nanoparticles and animals, advantages of 
nanoparticles, and effects of nano-selenium. The review includes research findings 
from the years 2000–2017.
Nanotechnological modifications
Nanoparticle (NP) systems appear to be a promising alternative to peroral drug delivery1 
as well as nutritional supplements.2 The effects of bioactive compound supplements – 
omega-3 and omega-6 fatty acids, probiotics, prebiotics, vitamins, and minerals – in 
nanoparticulate preparations have already been dealt by numerous studies.3–16 Some 
applications of NPs in nutrition and medicine have already been approved for clinical 
use, and many others are at different stages of their development.17
The incentive to incorporate nanotechnology in nutrition has the following advan-
tages: taste and smell, administration and solubility, protection against oxidation and 
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enzymatic degradation, prolongation of residence time, and 
effective passage through the gastrointestinal tract enhanc-
ing the bioavailability of supplemented substances.18 The 
use of most perorally administered supplements carries a 
number of drawbacks such as insufficient residence time, 
low permeability and solubility, and instability during the 
production process (temperature, presence of oxygen, light) 
or in the gastrointestinal tract environment (pH, enzymes, 
presence of other nutrients), which can reduce the activity 
and potential health benefits of supplements.19 Thus, it is 
necessary to develop more appropriate products to ensure 
their physiological and therapeutic effect.20
The use of NPs is a promising alternative for the peroral 
application of supplements that could solve the mentioned 
shortcomings of traditional forms of supplements and pre-
serve their health benefits.1 The main advantages of NPs are 
shown in Figure 1.
Selenium NPs as a food additive
The nanoform of selenium attracts even more attention, 
thanks to its high bioavailability and lower toxicity than 
inorganic and organic forms,21–23 where inorganic compounds 
are more toxic than organic ones.24
The biological properties of selenium nanoparticles 
(SeNPs) depend on their size: smaller particles have a greater 
activity.25 Particle size affects the cellular intake of NPs; for 
example, in vitro absorption of 0.1 μm particles was found to 
be 2.5 and 6 times higher compared to 1 and 10 μm particles, 
respectively.26 With respect to this fact, in the preparation 
of dietary supplements, an appropriate particle size and 
morphology, as well as encapsulation material, should be 
chosen.27 A system based on the administration of food 
supplements encapsulated into NPs represents an important 
potential to improve the bioavailability of supplements with 
the possibility of modifying their properties, such as resis-
tance to adverse pH, digestion, and enzymatic cleavage.28
The advantage of nano-selenium (Nano-Se) is the pos-
sibility of using selenium in zero oxidation state (Se0), which 
presents low toxicity and excellent bioavailability compared 
to other oxidation states (Se+IV, Se+VI);22,25 however, it is 
very unstable and easily transformed into an inactive form. 
Although, its stabilization can be achieved by encapsulation 
into suitable nano-vehicles, for example, chitosan (CS)15 
(Figure 2).
Nanoscale selenium has a very wide range of biomedical 
applications. Its effect on the reduction of oxidative stress is 
Figure 1 Diagram showing the main advantages of nanoparticles (NPs).
Note: Data from various studies.2,22,28,201–204
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very well known.12,29 Gao et al30 demonstrated the antioxi-
dant properties of hollow spherical SeNPs reducing the risk 
of selenium toxicity. Besides its use as an antioxidant with 
reduced risk of toxicity, Nano-Se also possesses potential as 
a chemopreventive agent.22 The results of numerous studies 
indicate that Nano-Se can be more helpful in cancer chemo-
prevention as a potential anticancer drug,9,31–34 as well as an 
anticancer drug delivery carrier.32,35,36 Many studies have 
shown the antimicrobial effect37–39 and antifungal activity of 
Nano-Se.40 In addition, its protective effects against metal 
intoxication were well documented.41–43 Moreover, the immu-
nostimulatory effect of nanoscale selenium was confirmed.8,44 
Last but not least, Nano-Se has beneficial effects on a number 
of physiological functions.13,45–47
Besides these unique abilities of Nano-Se, its antiprotozoal 
effect was described. Based on in vitro and in vivo studies, 
biogenic SeNPs can be considered as a novel therapeutic 
agent for the treatment of localized lesions typical of cutane-
ous leishmaniasis caused by Leishmania major.48 The anti-
leishmanial activities of SeNPs against Leishmania infantum 
were also described. SeNPs have more growth-inhibitory 
effect on promastigotes than selenium dioxide (SeO
2
), while 
the IC
50
 (half minimal [50%] inhibitory concentration) was 
determined to be 25 and 50 μg⋅mL−1, respectively.49
The main effects of the SeNPs found in various scientific 
studies are summarized in Figure 3.
Synthesis of SeNPs
SeNPs can be synthesized chemically,50 or using physical 
procedures,51 or can even be obtained by biological way – 
using microorganisms or plant extracts, the so-called green 
synthesis.52,53
Chemical synthesis
In terms of chemical synthesis, SeNPs are usually prepared 
by reduction of selenious acid solution by ascorbic acid 
in the presence of polysaccharides (Figure 2) such as CS, 
glucomannan, acacia gum, or carboxymethylcellulose.50 CS 
is positively charged, biocompatible, non-immunogenic, 
nontoxic, pH sensitive, and biodegradable, and is there-
fore a suitable component for oral administration for a 
wide range of biomedical and nutritional applications.54–56 
It has been extensively examined in the pharmaceutical 
industry due to its potential in the development of medi-
cation delivery systems.57 In the molecular structure of 
polysaccharides, reactive amino, hydroxyl, or carboxyl 
groups are present, which have a substantial effect on the 
formation, stabilization, and growth of SeNPs.50 After the 
synthesis of NPs, their ex situ characterization is performed 
using different biophysical methods including electron 
microscopy. The obtained monodisperse spherical selenium 
particles are very stable in solution16 and can be used as 
dietary additive.14
Figure 2 Scheme of preparation of selenium nanoparticles (SeNPs). 
Notes: For the synthesis of SeNPs, the selenious acid solution (aqueous solution of SeO2) (1) is mixed with an aqueous solution of a polysaccharide, for example, chitosan 
(2), and ascorbic acid solution (3), which gradually transforms the initially colorless solution into a red color solution (4). In the next step, elemental SeNPs are coated with 
chitosan, and the result is encapsulated nano-selenium form (5, in detail 6).50,213
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The effects of selenium encapsulation into CS NPs were 
investigated by Zhang et al.2 The study showed that encap-
sulation of selenium compounds into CS NPs is an effective 
way of delivering selenium to cells in which selenium reten-
tion increases, while reducing the risk of DNA damage. The 
development of NP–selenium compound systems may, in 
the case of low selenium level, significantly improve the 
bioavailability of selenium and facilitate the expression of 
selenoproteins.
Another example for chemical preparation of SeNPs is 
ionic liquid-induced synthesis with sodium selenosulfate 
as selenium precursor, in the presence of polyvinyl alcohol 
stabilizer, which can produce spherical SeNPs in the size 
range of 76–150 nm.58
Physical synthesis
Among the physical techniques for the preparation of SeNPs, 
synthesis by pulsed laser ablation (PLA) or deposition was 
described in a study.51 Generally, physical methods have 
distinct advantages over the chemical ones, since these 
often require a final calcination step, which makes them 
unsuitable for certain applications. Furthermore, with sput-
tering and laser ablation, the stoichiometry of the material 
is maintained.59 In PLA, the size of the nanoclusters can be 
controlled by laser parameters, such as fluence, wavelength, 
and pulse duration, as well as by ambient gas conditions, 
such as pressure and flow parameters.60 However, physical 
techniques are not widely applied for producing SeNPs.
Biological synthesis
Originally, SeNPs, like other NPs, were synthesized by 
various chemical methods. However, the high cost of pro-
duction and the presence of toxic by-products led to the 
development of novel methods of NPs synthesis.61 Biological 
organisms such as plants, fungi, or bacteria have the ability to 
convert some toxic metal ions to less toxic forms including 
metal precipitants or NPs.62–64 Thanks to this advantage, 
researches focused on their use for synthesizing NPs with an 
ecofriendly approach.65–68
As for green synthesis, SeNPs were synthesized, for 
example, using the following plant extracts: aqueous extract 
of Allium sativum,69 tea extract,70 Clausena dentata plant leaf 
Figure 3 Diagram showing the main effects of selenium nanoparticles (SeNPs).
Note: Data from various sources.7,10,12–14,21,29,43,46,47,52,155,176,180,205–212
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extract,71 Undaria pinnatifida polysaccharide solutions,31 and 
Terminalia arjuna leaf extract.42
Biosynthesis of nanomaterials using plant extracts has 
more advantages than other biological methods because it is 
inexpensive and does not require any special conditions.52
NPs synthesis using bacteria is more effective than chemical 
synthesis, thanks to the following advantages: 1) high purity 
of selenium spheres (which are relatively regular and 
uniform, and their size depends on the bacterium), 2) cheaper 
and faster production process, and 3) better possibility to 
control the parameters.72
Microorganisms are capable of synthesizing metal NPs.53 
Different bacterial strains are able to reduce Se+IV (selenite) 
and (or) Se+VI (selenate) to less toxic Se0 with the formation 
of SeNPs. The biogenic SeNPs have exhibited promising 
application perspectives in the field of medicine, biosensors, 
and environmental remediation.73 Interestingly, two halo-
tolerant Bacillus megaterium strains (BSB6 and BSB12), 
isolated from saline mangrove habitat without selenium 
contamination, were found to be capable of reducing Se+IV 
to elemental selenium, even in the presence of high salt 
concentrations.74
The synthesis of SeNPs by macro- or microorganisms, 
due to the diversity of reducing enzymes in organisms, 
involves morphological and shape changes of the particles. 
By changing the redox state, the reducing enzymes of micro-
organisms convert metal ions (Se−II) to SeNPs without charge 
(Se0). The biological activity of SeNPs includes their protec-
tive role against DNA oxidation.53 It was found that certain 
anaerobic bacteria respire toxic selenium oxyanions and as a 
result cause extracellular accumulation of elemental selenium 
(Se0). The spectral properties differ considerably from those 
of amorphous Se0 formed by chemical oxidation of hydrogen 
selenide (H
2
Se) and of black, vitreous Se0 formed chemically 
by reduction of selenite with ascorbate. The microbial 
synthesis of Se0 nanospheres results in unique, complex, 
with compact nanostructural arrangement of Se atoms. This 
probably reflects a wide diversity of enzymes involved in the 
dissimilatory reduction that are slightly different in various 
bacteria. Remarkably, these conditions cannot be achieved 
by current methods of chemical synthesis.66
Different types of bacteria have been used for the biosyn-
thesis of SeNPs, such as the species of phylum Proteobacteria 
(Escherichia coli ATCC 35218,75 recombinant E. coli,76 Ralsto-
nia eutropha,77 Enterobacter cloacae Z0206,78 Pseudomonas 
aeruginosa ATCC 27853,79 Klebsiella pneumoniae,80,81 Pan-
toea agglomerans,25 Zooglea ramigera,82 Rhodopseudomonas 
palustris strain N,83 Shewanella sp. HN-41,84 Azoarcus 
sp. CIB,85 Burkholderia fungorum,86 Stenotrophomonas 
maltophilia39), Firmicutes (Lactobacillus casei,72,81,87 
Lactobacillus acidophilus [LA-5],72 Lactobacillus helve-
ticus [LH-B02],72 Enterococcus faecalis,53 Streptococcus 
thermophilus,72 Staphylococcus carnosus,88 Bacillus sp. 
MSh-1,89 Bacillus subtilis,65 Bacillus mycoides SelTE01,38 
Bacillus licheniformis JS290), Actinobacteria (Streptomyces 
sp. ES2-5,73 Bifidobacterium BB-1272), and Cyanobacteria 
(Arthrospira [Spirulina] platensis91).
For in vivo synthesis of Nano-Se, unicellular eukaryotic 
organisms, such as the protozoa Tetrahymena thermophila 
SB210,92 yeast Saccharomyces cerevisiae,93 and a genetically 
modified Pichia pastoris,94 or even multicellular organ-
isms, such as a fungus from the phylum of Ascomycota 
(Aspergillus terreus95), were used.
Problems with traditional forms of 
oral supplementation of selenium 
and potential benefits of SeNPs
The bioavailability of various chemical forms of selenium has 
been the subject of many studies. For instance, Mahan et al 
stated that the degree of selenium absorption is much lower in 
ruminants than in nonruminants; after oral supplementation, 
the selenium uptake in sheep was only 34%, whereas in pigs 
85%.96 In ruminants, the microbial digestion in the rumen 
and reticulum precedes its assimilation in the abomasum and 
microbial digestion in the small intestine.97,98 Ruminal micro-
organisms partially transform selenium supplements into 
insoluble forms, such as elemental selenium and selenides, 
which are unavailable to animals, and thus, the absorption 
of selenium from the digestive tract is reduced.99
To avoid this negative phenomenon of reduced selenium 
absorption due to microbial digestion in ruminants and 
improve the availability of this microelement, polymer NP 
systems with in vivo potential have been proposed.
This technology was implemented using the Eudragit® 
RL and Eudragit® RS polymers.100 These nonbiodegradable 
polymer NPs were already used in 2005 to encapsulate the 
lipophilic cyclic undecapeptide cyclosporin A (CyA) for 
oral administration in rabbits for the prevention of graft 
rejection and the treatment of autoimmune diseases. CyA 
was encapsulated by nanoprecipitation in mentioned NP 
polymers, and its relative bioavailability from both prepara-
tions ranged from 20% to 35%.101 The design of selenium 
in the nanoform for oral administration to ruminants was 
proposed as late as 2010 by Romero-Pérez et al,100 who 
monitored the in vitro effect of sodium selenite (Na
2
SeO
3
) 
encapsulated in polymeric NPs by nanoprecipitation and 
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emulsion-evaporation methods using two different solvents 
– ethanol and acetone. Nanoprecipitated NPs were spherical 
and had a greater particle size variability; on the contrary, 
the NPs produced by the emulsion-evaporation technique 
were both spherical and irregular in shape and homogeneous 
in size. The size of NPs ranged from 30 to 200 nm. Higher 
particle size, zeta potential, and polydispersity index were 
found for the NPs produced by the nanoprecipitation method 
using ethanol as the solvent of polymers. The release of 
selenium from NPs was monitored in vitro at different pH 
values and was higher in the strongly acidic environment 
(pH less than 4), which is a prerequisite for providing better 
accessibility of this element in the abomasum. At pH values 
lower than 4, selenium release increases by 62%100 compared 
to pH 6. The pH in the rumen ranges from 5.5 to 6.5. Thus, 
the sheep rumen essentially does not absorb selenium.97 On 
the contrary, the pH in the abomasum is less than 4; under 
this condition, the largest amount of selenium is released 
from the particles. NPs increase the bioavailability of this 
element because at pH 6 only a small amount of selenium 
is released (by rumen microorganisms) and the remaining, 
bigger part, is released then in the more acidic environment 
of the gastrointestinal tract, which guarantees its better 
availability.100
SeNPs evince, in addition to better selenium avail-
ability, much lower toxicity compared to other selenium 
compounds.22,23 For example, in mice, SeNPs showed much 
lower toxicity measured by median lethal dose (50%, LD
50
), 
liver impairment, and short-term toxicity.23
Mechanism of passage of NPs 
through intestinal mucosa
Oral administration of NPs is considered to be the most 
appropriate and cost-effective method of supplementation. 
However, absorption of NPs may also be made more difficult 
by the presence of absorption barriers in the digestive tract. 
It is necessary to overcome two barriers in the gastrointestinal 
tract for the absorption of NPs, which are mucus covering 
the intestinal mucosa and the intestinal mucosa.1
The intestinal epithelium is composed of a series of spe-
cialized cells, primarily enterocytes, goblet cells, and M cells. 
One of the main functions of enterocytes is to control the 
transition of macromolecules and allow the absorption of 
nutrients. The goblet cells secrete mucus consisting of a high-
molecular-weight glycoprotein (mainly mucin) suspended in 
the electrolyte solution,102 which covers with the adherent 
layer the mucous membrane of the intestine. Their primary 
function is to protect the intestinal mucosa from potential 
pathogens or chemicals and maintain a different pH between 
the lumen and the mucosal surface of the intestine.1
NPs can theoretically pass through the intestinal epi-
thelium in two ways: paracellular (between adjacent cells) 
or transcellular (through the cells) (Figure 4).102 Under 
physiological conditions, the first way is restricted by a 
narrow region of intercellular spaces and by the tightness of 
the junctions between the epithelial cells (pore diameter is 
between 0.3 and 1.0 nm).103 Transcellular transport of NPs 
takes place through a process called transcytosis, which 
starts with endocytosis in the apical membrane of the cells. 
Subsequently, the NPs are transported through the cells and 
released on the basolateral pole.104
Intestinal epithelial cells are capable of transferring NPs 
with mineral elements, although their capacity is limited. 
Transcellular transport begins with endocytosis (pinocytosis 
or macropinocytosis). It is an active process requiring 
energy for the internalization of NPs. Macropinocytosis 
is actin-dependent but is not regulated by receptors, and 
a large amount of fluid with particles smaller than 5 μm 
can be internalized through it.105 The absorption of NPs is 
influenced by electric charge, surface hydrophobicity, and 
size.106 The epithelial cell membrane of the gastrointestinal 
tract is composed of lipids, so that hydrophobic NPs have a 
higher absorption efficiency than hydrophilic particles. The 
absorption of NPs of 100 nm in the gastrointestinal tract is 
15–250 times higher than that of larger-sized NPs.107
Application of SeNPs through oral 
administration
Nano-Se as an antioxidant
Nano-Se possesses better antioxidant capability than other 
chemical forms of selenium while reducing the risk of sele-
nium toxicity. Wang et al22 demonstrated the antioxidant 
properties of SeNPs that evinced lower toxicity than sele-
nomethionine (SeMet).
Zhang et al108 studied the effect of elemental Nano-Se on 
the activity of glutathione peroxidase (GPx) in the liver of 
weanling pigs (Duroc × Landrace × Yorkshire) in comparison 
to inorganic form of selenium. The animals had significantly 
higher activities of GPx at a concentration range of 0.50 and 
1.0 mg Se⋅kg−1 diet in the form of Nano-Se than Na
2
SeO
3
.
effect of SeNPs on reproductive performance
Oxidative stress affects the fertility potential of spermatozoa 
by lipid peroxidation which can lead to sperm dysfunction.109 
Selenium deficiency leads to the occurrence of abnormal mito-
chondria in goat spermatozoa, and Nano-Se supplementation 
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increases selenium concentration in testes, and testicular and 
semen GPx activity. In addition, it has a protective effect 
on membrane integrity and the tight arrayment of the mid-
piece of the mitochondria. To study the effects of elemental 
Nano-Se in the diet on the testes ultrastructure, ejaculate 
quality and GPx activity in goats were investigated. The 
animals were administered with Nano-Se in the declared 
selenium dose of 0.3 mg⋅kg−1 of the feed dry matter (DM) 
for 12 weeks from weaning to sexual maturity. The results 
showed that the level of selenium in testes and the activity of 
GPx and ATPase in the ejaculate significantly increased in 
the group supplemented with nanoscale selenium compared 
to the control group. The quality of the ejaculate (volume, 
density, motility, and pH) was not affected by the addition of 
selenium, but the percentage of abnormal spermatozoa in the 
control group of goats was significantly higher compared to 
the SeNPs group. Using transmission electron microscopy, it 
was found that in selenium-deficient goats the sperm plasma 
membrane was damaged, and there were abnormalities in the 
mitochondria midpiece of spermatozoa.13
Use of Nano-Se for increasing hair follicle 
development and fetal growth
The study of Wu et al46 demonstrated the importance of 
maternal administration of selenium at nano size for improv-
ing the hair follicle development and promoting the growth of 
fetus. This was attributed to the influencing antioxidant status 
in the fetal skin. An increase in the antioxidant defence results 
in a decrease of reactive oxygen species (ROS) generation, 
leading to upregulation of IGF-1 and its receptor (IGF-1R) 
which are crucial for the improvement of both properties.
In cashmere goats, SeNPs have a positive effect on the 
amount of wool. The administration of 0.5 mg⋅kg−1 diet 
(containing 1,500 mg Se⋅kg−1) in the period from 30 days 
before conception to 110 days of gestation was manifested 
in their fetuses with significantly higher expression levels of 
Figure 4 Diagram of nanoparticle transport across the intestinal mucosa of the small intestine. Particles pass either paracellularly, that is, between adjacent cells, or by 
a transcellular pathway that has been more explored. The transcellular transition takes place via normal enterocytes or M cells. A, paracellular transport; B, transcellular 
transport: transcytosis through M cell; C1, transcytosis through enterocyte, first mechanism; C2, transcytosis through enterocyte, second mechanism; 1, apical membrane 
of enterocyte; 2, the basolateral membrane of the enterocyte. M cells form a row of vesicles before transfer from subepithelial dome dendritic cells (SDDCs) to T- or 
B-lymphocytes (B). Uptake of nanoparticles by microvilli of enterocytes is often followed by endosome formation, microvesicular bodies (MvBs) genesis, and their fusion 
with lysosomes, and then the particles are transported to lamina propria (C1). Another mechanism of enterocyte utilization for transepithelial transport involves uptake into 
endosomes, MvB formation, fusion with Golgi apparatus, and exosomal transfer to lamina propria (C2). This is followed by transport into the bloodstream and the lymphatic 
system.102,214
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the GPx, IGF-1, and IGF-1R genes in skin. In addition, increased 
GPx and superoxide dismutase (SOD) activities, and IGF-1 
and selenium concentrations in both skin and blood serum 
at 110 days were observed. Moreover, a significantly lower 
malondialdehyde (MDA) production in both skin and serum 
which affected the antioxidant status in skin of the fetuses, 
and significantly increased the number of their secondary 
hair follicles, was observed. The low level of ROS probably 
upregulates IGF-1 and IGF-1R, which favorably influences 
the development of hair follicles in the fetus. In addition, the 
weights of fetus and placenta were significantly higher in 
SeNPs-receiving group than those in control group.46
Antiviral and antibacterial effects 
of SeNPs
SeNPs have attracted substantial attention due to their unique 
antimicrobial activity.53,110–114 Selenium is an essential trace 
element regulated by cellular redox homeostasis115–117 and 
is an integral component of selenoproteins controlling 
some crucial biological processes, such as ROS elimination 
and specific enzyme modulation.118,119 Selenium deficiency 
can result in susceptibility to viral infections. The antiviral 
capability of SeNPs, together with other advantages such 
as low toxicity and excellent activity, has recently attracted 
increased attention. The mortality of the H1N1 influenza 
virus-infected selenium-deficient mice was 3 times higher 
compared to those receiving Na
2
SeO
3
 at the dose of 0.5 mg 
Se⋅kg−1, and mice with low serum selenium concentrations 
showed a marked reduction in body weight (BW) and lower 
levels of TNF-α and IFN-γ.120 For improving the immune 
response in the body, the administration of SeNPs can also 
be an efficient realizable approach.
Li et al121 synthesized oseltamivir (OTV) surface-modified 
SeNPs (Se@OTV) with superior antiviral properties and 
restriction on drug resistance. Although the clinical applica-
tion of OTV itself as an effective antiviral agent is ordinarily 
limited by the appearance of drug-resistant viruses, OTV 
decoration of SeNPs evidently inhibited H1N1 influenza 
virus infection and showed less toxicity. Se@OTV interfered 
with the entry of H1N1 into host cells through inhibiting the 
activity of influenza virus glycoproteins – hemagglutinin and 
neuraminidase. Modified NPs were able to prevent H1N1 
from infecting Madin-Darby canine kidney cells and block 
chromatin condensation and DNA fragmentation. In addition, 
they inhibited the generation of ROS as well as the activa-
tion of phosphorylation of cellular tumor antigen p53 and 
Akt. Thus, ROS play a pivotal role in the antiviral action. 
The presence of H1N1 virus increased the intracellular ROS 
generation from 100% (control) to 380%, and OTV and 
SeNPs slightly inhibited their production to 270% and 210%, 
respectively, whereas Se@OTV markedly decreased the ROS 
generation (120%). It follows that Se@OTV are promising 
efficient antiviral pharmaceuticals against highly infectious 
respiratory disease caused by H1N1,121 which belongs to 
influenza A-type viruses.122
SeNPs also show excellent antibacterial activity. With 
SeNPs biosynthesized by R. eutropha, 99% inhibition of 
growth of P. aeruginosa, S. aureus, E. coli, and Streptococcus 
pyogenes at the concentrations of 100, 100, 250, and 
100 μg⋅mL−1, respectively, was observed. Moreover, the 
concentration of 500 μg⋅mL−1 of SeNPs was found to inhibit 
the growth of pathogenic fungi Aspergillus clavatus. The 
antimicrobial efficacy of SeNPs can be comparable with 
commercially available antibiotic ampicillin.77 SeNPs 
synthesized by another bacterial species E. faecalis can be 
used as an antistaphylococcal element to effectively prevent 
and treat S. aureus infections.53 SeNPs with application of 
bioactive glass scaffolds (45S5Bioglass®) and poly(lactic-
co-glycolic acid) (PLGA) (45S5Bioglass®/SeNPs and 
45S5Bioglass®/PLGA/SeNPs) showed a considerable anti-
bacterial activity against Gram-positive bacteria, S. aureus 
and Staphylococcus epidermidis.114 In another study, Yang 
et al123 introduced the antibacterial effect of Qe/CdSe/ZnS 
(quercetin/cadmium selenide/zinc sulfide) nanoparticles 
(QCZNPs) against drug-resistant E. coli and B. subtilis 
in vitro. QCZNPs showed markedly more effective anti-
bacterial activities than Qe or CdSe NPs. The in vitro study 
of Wang and Webster37 showed that the selenium coatings 
on polycarbonate medical devices significantly inhibited 
S. aureus growth to 27% compared with an uncoated poly-
carbonate surface after 72 hours.
The antimicrobial activity of SeNPs depends on the 
way they are synthesized. Piacenza et al38 evaluated the 
antimicrobial efficacy of spherical biogenic selenium 
nanostructures embedded in organic material produced 
by B. mycoides SelTE01 in comparison with two different 
chemical SeNP classes produced using L-cysteine or ascorbic 
acid. The antimicrobial activity was tested on P. aeruginosa 
and S. aureus biofilms grown onto hydroxyapatite-coated 
clinical devices and surfaces. After 6 or 24 hours of 
Na
2
SeO
3
 exposure, biogenic SeNPs evinced the same 
effective antibiofilm activity against both tested strains at 
0.078 and 0.3125 mg⋅mL−1, respectively. On the contrary, 
chemically synthesized SeNPs at the highest tested concen-
tration (2.5 mg⋅mL−1) showed only moderate antimicrobial 
activity. Cremonini et al39 reported that SeNPs synthesized by 
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Gram-negative S. maltophilia and Gram-positive B. mycoides 
achieved much stronger antimicrobial effects compared 
with synthetically prepared SeNPs. Both biogenic types of 
NPs were active at low minimum inhibitory concentrations 
against a number of clinical isolates of P. aeruginosa. It was 
interesting that after an exposure of human dendritic cells 
and fibroblasts to all three SeNPs, the following phenomena 
were not observed: 1) loss of cell viability, 2) increased 
release of ROS, and 3) significant increase in the secretion 
of pro-inflammatory and immunostimulatory cytokines. 
Therefore, SeNPs appear to be reliable candidates for safe 
medical applications, either alone or in combination with 
traditional antibiotics, to inhibit the growth of P. aeruginosa 
clinical isolates.
Anticancer effects of SeNPs
SeNPs have also showed remarkable anticancer activity52,123–128 
and exhibit high potential in cancer chemotherapy and as drug 
carriers.129–131 The anticancer effects of SeNPs are medi-
ated through their ability to inhibit the growth of cancer 
cells through induction of cell cycle arrest at S phase.32 The 
induction of the cell cycle arrest at the S phase is mediated 
by deregulation of the eIF3 protein complex.132 A recent 
study revealed that cell membrane plays an important role 
in SeNPs-induced toxicity in cancer cells. SeNPs treatment 
changes the biomechanical properties of cancer cells, in par-
ticular remarkably decreases the adhesion force and Young’s 
modulus.133 Besides unique anticancer efficacy, SeNPs have 
been proved to present a better selectivity between normal 
and cancer cells than Se+IV at similar concentrations.31 SeNPs 
can be internalized selectively by cancer cells through endo-
cytosis and induce cell apoptosis by triggering apoptotic 
signal transduction pathways.134–136
Nano-Se as an anticancer drug
Nano-Se possesses higher anticancer efficacy than other sele-
nium compounds.119 A key mechanism for the chemopreven-
tive effect is the induction of glutathione S-transferase (GST) 
by selenium.22 The activity of GST in the case of Nano-Se 
administration increased much earlier and more markedly 
than in the case of SeMet and selenite.22,137
Yanhua et al127 suggested that novel selenium-substituted 
hydroxyapatite NPs (SeHAN) could be a new promising 
anticancer agent to provide both survival advantage and lower 
toxicity in nude mice model of human hepatocellular carci-
noma. The overall survival rate of nude mice in the control, 
pure hydroxyapatite, and SeHAN groups was 50.00%, 
76.92%, and 100.00%, respectively. Blood biochemical 
studies showed that SeHAN group had significantly lower 
toxicity on the liver and kidney functions.
In highly metastatic breast cancer mice model, a better 
prognosis could be achieved by oral administration of 
SeNP-enriched Lactobacillus brevis. Both components are 
immunostimulators, and enhanced immune response in 
cancer-affected mice. Moreover, lactic acid bacteria (LAB) 
can reduce selenium ions to elemental SeNPs and deposit 
them in intracellular spaces. When LAB in combination 
with SeNPs were administered to cancer-bearing mice, a 
significant increase in natural killer cell cytotoxicity and 
delayed-type hypersensitivity responses, as well as a high 
level of IFN-γ and IL-17, compared to the control mice or 
mice that received L. brevis alone, was observed. In addition, 
an extended life span and a decline in the tumor metastasis to 
the liver were recorded in this group compared to the other 
two groups of mice.44
Chen et al31 reported that SeNPs fabricated in U. pinnatifida 
polysaccharide solutions induced mitochondria-mediated 
apoptosis in A375 human melanoma cells. Treatment of this 
cancer cell line with Nano-Se resulted in a dose-dependent 
cell apoptosis manifested by DNA fragmentation and phos-
phatidylserine translocation.
Sonkusre et al34 introduced biologically synthesized 
SeNPs by B. licheniformis JS2 and developed a method 
for extraction and purification of intracellular NPs. These 
neutral-charged, non-agglomerating SeNPs at a concentra-
tion as low as 2 μg Se⋅mL−1 were efficacious in inhibiting 
proliferation and inducing caspase-independent necrosis 
to human prostate adenocarcinoma cells (PC3) without 
causing any significant toxicity to human peripheral blood 
mononuclear cells.
Luo et al32 examined the in vitro antiproliferative effects 
of SeNPs (Nano-Se0, 10–40 μmol⋅L−1) on HeLa (human 
cervical carcinoma) cells and MDA-MB-231 (human breast 
carcinoma) cells by optical microscopic inspection and MTT 
assay. Nano-Se0 effectively inhibited the growth of cells 
of both the cancer cell lines in a dose-dependent manner. 
The morphology analysis with atomic force microscopy 
showed that the HeLa cells treated with 10 μmol⋅L−1 Nano-
Se0 were rough and shrunken with truncated lamellipodia 
at the terminal part of the cells. Flow cytometric analysis 
demonstrated that HeLa cells were arrested at S phase of the 
cell cycle after exposed to mentioned amount of Nano-Se0 
(10 μmol⋅L−1).
It was found that anticancer activity of SeNPs correlates 
with the level of ERα in breast cancer cells. SeNP-induced 
cell death and expression of apoptotic markers (pp38, 
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Bax, and cytochrome c) were significantly higher in 
ERα-positive cells (MCF-7) but not in ERα-negative cells 
(MDA-MB-231).33
Nano-Se as an anticancer drug delivery carrier
Besides their direct anticancer effects, SeNPs have been 
appointed as potential anticancer drug delivery carriers.32,35 
A key factor that usually contributes to nanomaterial-based 
drug cytotoxicity is cellular uptake.35 The nanosize of these 
materials allows an efficient uptake by various cell types and 
selective drug accumulation at target sites.26 Like other chemo-
therapeutics, the effective cytotoxicity of nanomaterial-based 
drugs usually requires a high level of accumulation within the 
cancer cells.138 Nanomaterials tend to accumulate in cancer 
cells through a passive targeting process128 and often serve 
as “nanocarriers” for chemotherapeutics.35,139–147 Moreover, 
the usage of various surface decorators enhances the cellular 
uptake and anticancer efficacy of nanomaterials;35,128,135 for 
example, Yang et al128 developed a simple and solution-phase 
method for functionalization of SeNPs with Spirulina poly-
saccharides (SPS). In addition, they found that SPS surface 
decoration significantly enhanced the cellular uptake and 
cytotoxicity of SeNPs against several cancer cell lines. The 
action mechanism of SPS-SeNPs was grounded in inhibi-
tion of cancer cell growth through induction of apoptosis, 
as evidenced by an increase in sub-G1 cell population, DNA 
fragmentation, chromatin condensation, and phosphatidyl-
serine translocation. In another study, Yang et al148 designed 
and synthesized folic acid-conjugated SeNPs (FA@SeNPs) 
as cancer-targeting agents; the anticancer efficacy of FA@
SeNPs was synergistically enhanced by radioactive 125I seeds, 
and these NPs inhibited colony formation ability, which 
showed that functionalized SeNPs can be used as a radiation 
sensitizer for 125I seeds for cancer therapy.
Chan et al129 reported that, based on the Auger-electron 
effect and Compton effect of Se atoms, cancer-targeted 
SeNPs in combination with 125I seeds achieve synergetic 
effects for inhibition of cancer cell growth and colony 
formation by inducing cell apoptosis and cell cycle arrest. 
In addition, these could be used as a safe and effective agent 
for next-generation cancer chemoradiotherapy in clinical 
applications. The action mechanism showed the activation of 
intracellular ROS overproduction to regulate p53-mediated 
DNA damage apoptotic signaling pathways and MAPKs 
phosphorylation as well as preventing the self-repair of 
cancer cells simultaneously.
SeNPs can be used as a carrier of 5-fluorouracil to achieve 
anticancer synergism, as introduced by Liu et al.35 A panel 
of five human cancer cell lines (A375, MCF-7, HepG2, 
Colo201, and PC3) evinced susceptibility to 5-fluorouracil 
surface-functionalized SeNPs (5-FU-SeNPs), with IC
50
 
values ranging from 6.2 to 14.4 μM. Remarkably, despite this 
potency, the 5-FU-SeNPs possess great selectivity between 
cancer and normal cells. Induction of apoptosis in A375 
human melanoma cells by 5-FU-SeNPs was evidenced by 
accumulation of sub-G1 cell population, DNA fragmentation, 
and nuclear condensation.
By comparing the effect of chemically prepared SeNPs 
on the behavior of cancer cells with that of other inorganic 
and organic selenospecies, similar alterations in terms of cell 
viability, proliferation, migration, and cell cycle arrest at the 
S-G2/M phase after exposure of hepatocarcinoma (HepG2) 
cells to SeNPs and selenocystine (SeCys2) were observed. 
In contrast, cells exposed to Se+IV showed evident signs of 
toxicity such as strong induction of apoptosis and a signifi-
cant population of cells in the sub-G1 phase compared to 
control cells. Se+IV, SeMet, and seleno-methylselenocysteine 
(Se-MetSeCys) did not evince any significant differences in 
comparison to non-treated cells. While SeNPs only partially 
inhibited the Cdk1 expression, Se+IV and SeCys2 reduced 
drastically its expression, which can be toxic for healthy 
cells. Cdk1 plays an essential role in cell cycle progression 
and mitosis entry, and its inhibition induces cell cycle arrest. 
These findings may pave the way for use of Cdk1-targeting 
SeNPs in mitotic cell death for cancer therapy.36
Nano-Se as a promising orthopedic implant material 
and an agent reducing bone cancer cell functions
Currently used metallic orthopedic implants possess certain 
problems such as poor prolonged osseointegration, stress 
shielding,149 and wear debris-associated bone cell death.150 
However, the greatest concern is corrosion as a result of 
continuous tissue exposure to metal. This limits orthopedic 
implant efficacy, especially in patients receiving implants 
due to bone cancer.151 Unfortunately, current orthopedic 
materials are not designed to prevent the occurrence or reoc-
currence of cancer.150 Selenium, due to its chemopreventive 
and chemotherapeutic properties,150,152–154 appears to be a 
promising anticancer biocompatible orthopedic implant 
material.151 Moreover, SeNPs may be used to effectively 
prevent and treat S. aureus155 and S. epidermidis114 infections, 
which are one of the leading causes of implant failure.155 
In addition, selenium did not evince inhibitory effect on the 
osteoblastic cell growth.156 Perla and Webster151 reported 
increased osteoblast adhesion on particulate surfaces of the 
compacts made from selenium compared with nonparticulate 
wrought titanium sheets. Moreover, osteoblast density was 
further increased on the surfaces of the selenium compacts 
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with nanometer particles. Tran et al150 fabricated titanium 
orthopedic material coated with a high-density selenium 
nanoclusters-doped surface. This novel biomaterial inhibited, 
compared to traditional untreated titanium, cancerous bone 
cell proliferation while promoting healthy bone cell func-
tions (including adhesion, proliferation, alkaline phosphatase 
activity, and calcium deposition).
SeNPs precipitated on a common orthopedic tissue engi-
neering material poly-L-lactic acid evinced, without simul-
taneous use of chemotherapeutics or pharmaceutical agents, 
selectively decreased long-term osteosarcoma cell density 
while promoting healthy, noncancerous, osteoblast func-
tions (for instance, up to 2 times higher alkaline phosphatase 
activity on selenium-coated tissue culture plates compared to 
osteoblasts grown on typical tissue culture plates), which is 
an impetus for follow-up studies to replace tumorous bone 
tissue with healthy bone tissue.157
effect of SeNPs on oxidative stress 
parameters
The effect of Nano-Se on oxidative stress parameters was 
compared with the effect of organically bound selenium in a 
study. Nano-Se was found to have a comparable efficiency in 
increasing plasma GPx activity in mice as SeMet but exhib-
ited much lower toxicity assessed on the basis of LD
50
, acute 
liver injury, and short-term toxicity. The results of the study 
showed that the nanoscale selenium can be administered as 
an antioxidant with a reduced risk of selenium toxicity.22 
Upregulation of selenoenzymes by elemental Nano-Se is also 
comparable to the effect of selenite and Se-MetSeCys, again 
with a significant reduction of acute toxicity.23,158,159
When comparing the effect of SeNPs (red selenium) 
(orally 1 mg⋅kg−1 BW) and inorganic selenium (Na
2
SeO
3
) 
(orally 1 mg Se⋅kg−1 BW) on antioxidant activities of neu-
trophils and hematological parameters in sheep for 30 days, 
it was found that on the 30th day thiobarbituric acid-reactive 
substance levels were significantly higher in both groups than 
in control animals, in contrary to the expected decrease in 
their levels. There were no significant differences between 
the packed cell volume and red blood cell count between the 
experimental groups and control group. The white blood cell 
count in the Nano-Se group showed a significant increase on 
the 20th and 30th days, and in the Na
2
SeO
3
 group on day 20, 
compared to the control group. There was also a significant 
increase in neutrophil count and a significant decrease in 
lymphocyte count on day 10 in the Nano-Se group compared 
to the second experimental group and the control group, and 
on the 20th and 30th days in both the experimental groups 
compared to the control group.12
The effect of SeNPs on heat shock proteins (HSPs) 
and HSP90 gene expression as additional oxidative stress 
parameters was investigated. Increased oxygen metabolism 
induces the formation of ROS.160 Intensive training of trotter 
horses can lead to oxidative stress, the formation of ROS, and 
consequently lipid, protein, and DNA damage.161 In addition 
to adaptive changes in protective enzymes (SOD, catalase 
[CAT],162 GPx163), oxidative stress to cells is known to induce 
increased production of stress or HSPs.162 Expression of HSPs 
is an adaptive mechanism against the disruption of cellular 
homeostasis164 and integrity165 during physical exercise.
A study of the effect of oral administration of SeNPs at 
0.5 mg⋅kg−1 concentration for 10 days on the expression of 
genes encoding HSP90 during intensive training in donkeys 
was performed.160
To assess the expression of the HSP90 gene in gluteus 
medius muscle, the total RNA was amplified by semiquan-
titative reverse transcription polymerase chain reaction. 
The results showed that serum concentration of selenium 
increased and the expression of the HSP90 gene decreased 
during rest after workload in the control group. As a response 
to intense exercise, in the experimental group with the 10-day 
administration of the SeNPs, both HSP90 expression and 
serum selenium concentration significantly increased. The 
induction of HSP resulting from SeNPs administration 
protected the cells from otherwise lethal stress levels. The 
result may explain the positive effect of short-term oral 
supplementation of SeNPs to donkeys on cell stability under 
stress conditions such as intensive training.160 Excessive dose 
of the antioxidants in combination with exercise may result 
in increased oxidative stress and impair exercise-induced 
adaptation, including direct induction of HSPs.166 Kojouri 
et al160 showed that oral supplementation of SeNPs in donkeys 
increased the expression of HSP90 in the gluteal muscle after 
24 hours of rest compared to the control group. Expression 
of HSP90 induced by supplementation of SeNPs can alter 
the buffering capacity of the cells in response to stressful 
conditions and protects them from further damage. The 
epigenetic effect of SeNPs and mechanism of their action 
on gene expression remains misunderstood.
In addition, the effect of SeNPs on blood urea nitrogen 
(BUN) in donkeys was investigated. It is known that urea 
in high concentrations causes oxidative stress and DNA 
lesions in cells.167 A study of the effect of oral administration 
of SeNPs on changes in BUN, creatinine, and total protein 
during intensive training in donkeys revealed that serum 
selenium concentration was significantly increased after 
SeNPs supplementation.29 The creatinine concentration in the 
experimental and control groups was significantly increased 
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in 2 hours of rest after training and rapidly declined in 
72 hours of rest after workout in the experimental group. 
A similar pattern was obtained with changes in BUN in the 
control group: its concentration was significantly increased 
in 2 hours of rest after training compared to the group which 
was dosed with SeNPs. These findings can explain the posi-
tive effects of SeNPs supplementation on serum changes in 
BUN levels and creatinine in response to intense training of 
donkeys. The positive effect of SeNPs could be related to 
the incorporation of selenium into proteins, such as seleno-
cysteine (SeCys) and its preventive role in oxidative tissue 
damage.29
Protective effects of Nano-Se
SeNPs in prevention of cisplatin (CIS)-induced 
reproductive toxicity
CIS, an anticancer alkylating agent,168 is widely used for 
cancer treatment.127,169–172 Despite its abundant clinical use, 
CIS possesses many side effects. It is known that CIS induces 
DNA adducts173 and forms DNA cross-links168 which inter-
fere with cellular metabolism, such as DNA replication and 
transcription, triggering cell death.
Rezvanfar et al168 demonstrated that Nano-Se can be, 
due to its strong antioxidant potential, useful to prevent 
CIS-induced gonadotoxicity. Coadministration of SeNPs 
significantly improved the serum testosterone, sperm quality, 
and spermatogenesis and reduced CIS-induced free radical 
toxic stress and spermatic DNA damage in male rats.
Protective effect of Nano-Se against polycyclic 
aromatic hydrocarbons
In mice exposed to oxidative stress induced by polycyclic 
aromatic hydrocarbon – 7,12-dimethylbenz(a)anthracene 
(DMBA), a known immunotoxin and carcinogen,174,175 which 
were fed with lamb meat supplemented with selenium in the 
nanoform, the protective effect of Nano-Se against DMBA-
induced immunotoxicity was observed. Compared to the 
control group of mice, also exposed to DMBA, survival of 
2 times higher amount of leucocytes (of which 3 times higher 
amount of phagocytes) was found, and their recovery in the 
bone marrow was twice higher, and the regenerative capac-
ity of granulopoiesis was 4 times higher. The study showed 
the functional dietary benefits of lamb meat enriched with 
selenium obtained by feeding lambs SeNPs.176
Use of SeNPs for minimization of risk of iron 
overabundance
An in vivo study compared the effect of SeNPs and Na
2
SeO
3
 
(both were administered at a dose of 1 mg⋅kg−1 BW for 30 days) 
on iron homeostasis and expression of genes coding for 
transferrin and transferrin receptor in sheep.7 The study 
showed that at the beginning of the administration selenium 
decreased the serum iron concentration and increased the total 
iron-binding capacity (TIBC). In addition, after 30 days, a 
reduction of the iron level in blood serum was observed. The 
group of animals dosed with SeNPs showed a significantly 
increased TIBC level after 20 days compared to the Na
2
SeO
3
 
and control groups, and significantly reduced iron serum 
level in comparison to the control group. At the beginning, 
the selenium administration stimulated the expression of the 
transferrin gene as well as the transferrin receptor gene, but 
at the end it suppressed their expression. This particular phe-
nomenon was especially observed in animals that received 
Na
2
SeO
3
. This effect could be related to hypoferremia and 
cellular internalization of iron. Expression of both genes 
was significantly increased in the SeNPs group after 20 days 
compared to the Na
2
SeO
3
 group.
SeNPs in treatment of heavy metal intoxication
SeNPs were found to be a promising agent to check the 
chronic toxicity caused due to heavy metals exposure. Prasad 
and Selvaraj42 studied the effect of SeNPs, synthesized using 
T. arjuna leaf extract, on human lymphocytes treated with 
arsenite (As+III). Studies on cell viability using MTT assay and 
DNA damage using comet assay revealed protective effect 
of SeNPs against As+III-induced cell death and DNA damage. 
This approach could be used in future for minimizing arsenic-
induced ROS-mediated toxic hazard, especially in an area 
with arsenic-contaminated groundwater and prevalence of 
arsenicosis.
The protective ability of SeNPs was also found against 
hexavalent chromium-induced thyrotoxicity.43 Toxic effect 
as a result of oxidative damage provoked by an intraperito-
neal administration of single dose of potassium dichromate 
(K
2
Cr
2
O
7
; 60 μg⋅kg−1 BW) to rats was manifested by signifi-
cant decrease in free T
3
 (triiodothyronine) and T
4
 (thyroxine) 
and glutathione levels, and significant increases in CAT, 
SOD, and MDA in the chromium-treated group compared 
to the controls. SeNPs administration resulted in correcting 
the hormonal levels as well as oxidative stress biomarkers 
compared to the K
2
Cr
2
O
7
-treated group.
Selenium also evinces protective effect against cadmium-
induced nephrotoxicity.41 Two-week oral administration of 
Na
2
SeO
3
 to rats treated with repeated intraperitoneal injection 
of Cd at sublethal dose (1.50 mg Cd⋅kg−1 BW for 14 days) 
reduced lipid peroxidation and restored GPx and SOD activi-
ties in the kidneys. Selenium supplementation facilitated 
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renal Cd accumulation in this group compared to Cd-exposed 
rats without selenium intake. Interestingly, X-ray diffrac-
tion analysis carried out on kidney fractions revealed CdSe 
and/or cadmium sulfide (CdS) NPs (about 62 nm in size). 
This indicates that Cd may induce the biosynthesis of red 
fluorescent CdSe and CdS NPs in the kidneys. The reduction 
of Cd-induced renal toxicity through selenium administration 
seems to lie in its ability to bind Cd in nanosized insoluble and 
fluorescent complexes. This implies that Cd complexation 
with Se or S at a nanoscale level could reduce oxidative stress 
induced by cadmium in the kidneys.
Nano-Se as an immunostimulator
Chronic oxidative stress reduces the respiratory burst 
response of neutrophils.177 Nano-Se, possessing an immunos-
timulating potential,44 evinces, in comparison with Na
2
SeO
3
, 
a stronger and faster effect in supporting the antioxidant 
defense system, based on increased chemotactic activity 
and respiratory burst activities of neutrophils.8 The effect 
of nanoscale selenium and Na
2
SeO
3
 (both supplements 
were administered at 1 mg⋅kg−1 BW, per os for 30 days) 
on neutrophils’ characteristics in sheep was compared. 
To determine the chemotactic activity and respiratory burst 
activities of the neutrophils, the leading front assay and the 
nitroblue tetrazolium (NBT) test (it is based on the reduction 
of the oxidant substances inside the phagocytic cells by NBT 
revealed by color change) were carried out on heparinized 
blood samples. It was found that in the Nano-Se group and 
the Na
2
SeO
3
 group, on the 10th, 20th, and 30th days, the 
neutrophil chemotactic activity increased significantly com-
pared to its basal value. In contrast to the Nano-Se group, in 
animals supplemented with an inorganic form of selenium, 
chemotactic activity at day 30 compared to day 20 decreased 
significantly. In the SeNPs group, a significant increase was 
observed after 10, 20, and 30 days compared to the control 
group and at 10 days as compared to the Na
2
SeO
3
 group 
(increase on day 10 was 24% in Nano-Se group and 5% in the 
group administered with Na
2
SeO
3
, compared to basal levels). 
In the Na
2
SeO
3
 group, a significant increase in chemotactic 
activity was observed after 20 days compared to the control 
group. Respiratory burst activity value showed a significant 
increase in both groups from day 0 to day 30.
effect of Nano-Se on microbial 
fermentation, nutrients digestibility, and 
probiotics support
The nanoscale selenium has also shown positive effects 
on rumen fermentation and increased nutrient conversion. 
A study of the effect of Nano-Se and selenium yeast (Se-
yeast) supplements (both at a dose of 4 g⋅kg−1 feed DM to 
meet the need for 4 mg Se) on food digestibility, ruminant 
fermentation, and urine purine derivatives in sheep14 dem-
onstrated a decrease in ruminal pH, ammonia nitrogen 
concentration, molar amount of propionate, and acetate/
propionate ratio. In addition, an increase in total ruminal 
volatile fatty acids in the Nano-Se and Se-yeast groups was 
also observed. Selenium intake significantly improved the 
in situ degradation of ruminal amylase-treated neutral deter-
gent fiber (aNDF) from Leymus chinensis and crude protein 
(CP) from soybean meal. The digestibility of DM, organic 
matter, CP, ethereal extract, aNDF, and acid detergent fiber 
throughout the digestive tract and urinary excretion of purine 
derivatives were also significantly affected by the addition 
of selenium. Ruminal fermentation was improved and feed 
conversion efficiency increased with Nano-Se compared 
to Se-yeast. Nano-Se can be considered as a preferentially 
available source of selenium for ruminants.14
Kheradmand et al40 investigated the effect of Nano-Se 
on antifungal activity of probiotics on Candida albicans, 
usually a commensal organism in humans, which can 
become pathogenic especially in immunocompromised 
individuals. After exposure to SeNPs-enriched Lactobacillus 
spp. (Lactobacillus plantarum and Lactobacillus johnsonii), 
a greater decline in viability of C. albicans than after its expo-
sure to non-Se-enriched LAB was observed. This indicates 
an increase in the antifungal activity of both bacterial strains 
by means of selenium. This phenomenon could potentially be 
used in anti-Candida probiotic formulations in future.
Nano-Se in treatment of metabolic 
disorders
Recently, promising nanocarriers for oral delivery of antidi-
abetic supplement to potentiate its curative effect were 
developed. Yin et al45 designed selenium-coated nano-
structured lipid carriers (SeNLCs) for enhancing the oral 
bioavailability and strengthening the hypoglycemic action of 
berberine, an antidiabetic phytomedicine. Berberine-loaded 
SeNLCs administered orally to rats greatly enhanced the 
bioavailability of berberine 6.6 times and evinced signifi-
cantly higher hypoglycemic effect than berberine solution as 
well as berberine-loaded nanostructured lipid carriers. Both 
properties were improved due to better sustained drug release 
and intestinal absorption of selenium nanocarriers.
Nano-Se has also been shown to be efficacious in the 
treatment of fatty liver disease (FLD). Hepatic steatosis 
(FLD) or fatty liver is a sign of a metabolic disorder affecting 
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50% of dairy cows immediately after calving, caused by 
ectopic fat deposition in the liver.178 Fatty liver can cause an 
inflammatory response in the liver that can lead to permanent 
liver damage and even to death. Without proper treatment, 
the mortality may reach up to 25%.179 Apart from changes 
in dietetic arrangement, the application of Nano-Se may be 
effective for the therapy of this disease.180 Hegedüs et al47 
reported a study of the effect of Nano-Se on FLD therapy 
in male Wistar rats which showed a low level of inflamma-
tion and free radical release in sick animals compared to the 
control group. This was confirmed by transmethylation ability 
and histological analysis of samples.47 Bioactive nanoscale 
selenium appears to be effective, but confirmation of its 
therapeutic effect requires further experiments.180
Safety and toxicity concerns of 
orally delivered SeNPs for use as 
food additives and drug carriers
Despite the growing interest of scientists on SeNPs and 
reporting of their wide range of positive effects, there are 
some concerns about their toxicity and objections to their 
use in clinical practice.
Many studies have demonstrated that the administration of 
selenium can prevent cancer and reduce its incidence.35,181,182 
Moreover, another potential of selenium was conclusively 
showed in the fight against cancer – through combination 
with chemotherapeutic and hormonal agents.183,184 Numer-
ous investigations have shown that both tissue and cell 
distribution profiles of anticancer drugs could be improved 
by nanotechnology.35,185,186 Nanosized anticancer drugs dis-
played increased antitumor efficiency and reduced serious 
side effects.187 It was revealed that selenium can sensitize 
cancer cells to conventionally used anticancer drugs. For 
example, Hu et al183 reported that selenium sensitized 
hormone-refractory prostate cancer cells to apoptosis induced 
by anticancer drug paclitaxel (Taxol) through enhancing 
multiple caspases. Li et al184 showed that the combination of 
doxorubicin with selenium enhanced apoptosis in the MCF-7 
human breast cancer cell line.
However, selenium evinces a narrow margin between 
beneficial and toxic effects. An effective dose of selenium 
as an anticancer agent approaches the toxicity limit, which 
substantially limits its clinical application. Nevertheless, 
the beneficial and toxic effects of selenium on health are 
greatly dependent not only on its concentration but also on its 
chemical form.35 While some studies reported that exceeding 
the tolerable upper intake level of 400 μg⋅day−1 in humans can 
lead to selenosis,179,180 Reid et al181,182,188 observed no obvious 
symptoms of selenosis in patients receiving 1,600 μg Se⋅day−1 
in the form of selenized yeast with SeMet as the major sele-
nium species. Even in those with an intake of 3,200 Se⋅day−1, 
only some symptoms of selenium toxicity did occur.
Studies performed with Nano-Se revealed that elemental 
selenium at nanoscale is much less toxic in comparison with 
the organic selenium compounds, such as SeMet22 and Se-
MetSeCys,23 and exhibited comparable efficacy to them in 
upregulating selenoenzymes and tissue selenium levels.
The in vitro free radical-scavenging efficiency of 
SeNPs was also found higher than organic and inorganic 
selenocompounds.22,159 For instance, based on the data of 
LD
50
, the in vivo toxicity of SeNPs was about 4–6 times lower 
than SeMet and Se-MetSeCys.22,23,159 The higher toxicity of 
selenite, SeCys2, and SeO
2
 is associated with their ability to 
initiate the oxidation of the thiol groups of proteins,189 which 
may lead to a change in the activity of essential enzymes con-
taining the sulfhydryl group.190 Selenite, compared to the same 
dose of Nano-Se, more markedly reduces hepatic GPx level 
and increases the production of MDA which is the product of 
lipid peroxidation as well as reducing the activity of antioxi-
dant enzymes SOD and CAT in the liver, than the same dose 
of nanoscale selenium.159 Wang et al investigated the effect of 
SeMet in mice which, compared to those with Nano-Se sup-
plementation, had strongly elevated levels of liver enzymes 
such as alanine aminotransferase, aspartate aminotransferase, 
and lactate dehydrogenase in the blood, over a long period 
of time, indicating acute severe liver injury.22 Acute toxicity 
due to Nano-Se occurs at a much higher dose compared to 
organically bound selenium forms. The median lethal dose 
(LD
50
) is 92.1 mg Se⋅kg−1 for Nano-Se, 25.6 mg Se⋅kg−1 for 
SeMet,22 and 14.6 mg Se⋅kg−1 for Se-MetSeCys.23
Studies showed that Nano-Se has a similar bioavailability 
in rats and much less acute toxicity in mice compared with 
selenite.191 The dose of red elemental Nano-Se that causes 
acute toxicity was approximately seven times that of Na
2
SeO
3
: 
the LD
50
 was about 113 and 16 mg Se⋅kg−1 BW, respectively. 
The reaction ratio of red elemental Nano-Se with glutathione 
in vitro was one-tenth of that of Na
2
SeO
3
.192
Moreover, the design of SeNPs-loaded CS microspheres 
(SeNPs-M) can offer a new way for further development of 
SeNPs with a higher efficacy and better biosafety.115 Based on 
acute toxicity test, SeNPs-M were much safer than selenite; the 
LD
50
 was around 18-fold of selenite. Furthermore, SeNPs-M 
possessed a strong antioxidant activity, as evidenced by a dra-
matic increase in selenium retention and also in the activities 
of GPx, SOD, and CAT. Oral administration of SeNPs-M can 
be considered as an effective way to supply selenium.
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Mittal et al193 synthetized bimetallic (Ag-Se) NPs which 
were used as anticancer agents for Dalton lymphoma cells. 
The Ag-Se NPs evinced strong anticancer activity at a lower 
concentration. In vitro viability of cells of the cancer line was 
reduced to 20% at 50 μg⋅mL−1 Ag-SeNPs.
Nano-Se is also less toxic than high-selenium protein. 
A study of the subchronic toxicity of these selenium forms 
performed in Sprague-Dawley rats191 (in both genders) fed 
with diets containing individual compounds at different 
concentrations (0, 2, 3, 4, and 5 mg⋅kg−1 Se) for 13 weeks 
showed significant abnormal changes in BW, hematology, 
clinical chemistry, relative organ weights, and histopathology 
parameters at the doses of 4 and 5 mg⋅kg−1 Se. The toxicity was 
more pronounced in the selenite and high-selenium protein 
groups than in the Nano-Se group, at the dose of 3 mg⋅kg−1 Se. 
Significant growth inhibition and degeneration of hepatic 
cells were found in the selenite and high-selenium protein 
groups. On the other hand, no changes attributable to admin-
istration of Nano-Se at the dose of 3 mg⋅kg−1 Se were found. 
No-observed-adverse-effect level (NOAEL; the highest 
experimental point that is without adverse effect) of Nano-Se 
in male and female rats was considered to be 3 mg Se⋅kg−1 
(equivalent to 0.22 and 0.33 mg⋅kg−1 BW⋅day−1 for males and 
females, respectively). On the contrary, the NOAELs of sel-
enite and high-selenium protein in both genders were consid-
ered to be 2 mg Se⋅kg−1 (equivalent to 0.14 and 0.20 mg⋅kg−1 
BW⋅day−1 for males and females, respectively).191
Therefore, it can be assumed that SeNPs have a much 
wider margin between beneficial and toxic effects than other 
selenocompounds and could serve as a suitable potential 
chemopreventive agent with reduced risk of toxicity.35
Higher IC
50
 of the SeNPs (41.5 ± 0.9 μg⋅mL−1) compared 
to SeO
2
 (6.7 ± 0.8 μg⋅mL−1) confirmed the lower cytotoxicity 
of the biogenic SeNPs on MCF-7 cell line.89
Regarding testing toxicity in mammalian models, Benko 
et al194 compared the toxicity of different selenium species in 
mice which were administered for 14 days at concentrations of 
0.5, 5, and 50 mg Se⋅kg−1 food, corresponding to an estimated 
4, 40, and 400 mg Se⋅kg−1 BW⋅day−1, respectively. A study on 
14-day murine subacute toxicity showed that toxicity was more 
pronounced when an inorganic selenium (Na
2
SeO
4
, NaHSeO
3
) 
was applied than after subacute application of Sel-Plex (a 
natural source of organic selenium consisting of predominantly 
selenoaminoacids [SeCys, SeMet] produced by S. cerevisiae), 
Nano-Se (synthetized by yogurt strains L. acidophilus, S. ther-
mophilus, and L. casei), or LactoMicroSe (selenium-enriched 
yogurt powder – L. acidophilus, S. thermophilus, and L. casei). 
The toxicity of selenium species decreased in the following 
order: selenate . selenite . Nano-Se . Sel-Plex . Lacto-
MicroSe. He et al195 reported a study on toxicity of Nano-Se 
in rats showing that supranutritional levels of SeNPs (at doses 
of 0.2, 0.4, 0.8, 2.0, 4.0, or 8.0 mg Se⋅kg−1 BW administered 
orally each day for 14 consecutive days) had no obvious 
toxic effects, and could be considered as potential candidates 
for cancer chemoprevention, although doses greater than 2.0 
mg Se⋅kg−1 BW induced chronic toxicity.
Shakibaie et al196 investigated the acute and subacute 
toxicity of the biogenic SeNPs synthetized by Bacillus sp. 
MSh-1and SeO
2
 in mice. The biogenic SeNPs were much less 
(26-fold) toxic than the SeO
2
. The toxicological evaluation 
showed that the LD
50
 values of SeO
2
 and SeNPs were 7.3 
and 198.1 mg⋅kg−1, respectively. No biochemical changes 
were observed from the administration of 2.5, 5, and 
10 mg SeNPs⋅kg−1, but a dose of 20 mg⋅kg−1 was accompanied 
with signs of toxicity including lower BW and changes in 
clinical chemistry and hematological parameters.
On the other side, studies on the toxicity of Nano-Se 
to aquatic organisms with relatively contradictory results 
appeared. Li et al137 found that a 10-day exposure to SeNPs 
at a dosage of 100 μg Se⋅L−1 compared to the same amount 
of Na
2
SeO
3
 in Medaka (Oryzias latipes) fish showed a greater 
toxicity due to hyperaccumulation. Gallego-Gallegos et al197 
evaluated the toxicity of SeNPs using 10-day waterborne 
and dietary exposures to larvae of Chironomus dilutus, a 
common benthic midge frequently used as a test organism 
for assessing the toxicity of sedimentary substances. They 
reported that even the lowest Se0 and SeNPs concentrations 
tested (2.81 μg⋅L−1 and 8.89 μg⋅g−1 dry weight, respectively) 
resulted in selenium bioaccumulation especially as SeMet. 
Inhibition of larval growth at higher concentrations due to 
both dietary and waterborne exposure was also observed.
However, both previous toxicological studies used chemi-
cally prepared NPs. Newer research works showed that the tox-
icity of Nano-Se also depends on the method of preparation; for 
instance, biogenic Nano-Se in comparison with that chemogenic 
is less toxic. Mal et al198 investigated the toxicity of biogenic 
Nano-Se formed by anaerobic granular sludge biofilms on 
zebrafish (Danio rerio) embryos in comparison with selenite and 
chemogenic Nano-Se. The biogenic Nano-Se formed by granu-
lar sludge biofilms showed an LC
50
 (50% lethal concentration) 
value of 1.77 mg⋅L−1, which was 3.2-fold less toxic to zebrafish 
embryos than selenite (LC
50
 = 0.55 mg⋅L−1) and 10-fold less toxic 
than chemogenic, bovine serum albumin-stabilized Nano-Se 
(LC
50
 = 0.16 mg⋅L−1). Interestingly, chemically synthesized 
Nano-Se particles of small (25–80 nm) and large (50–250 nm) 
size showed comparable toxicity on zebrafish embryos.
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Moreover, a study of Khiralla and El-Deeb199 also did 
not show any high toxicity of SeNPs biosynthesized by 
B. licheniformis assayed using larvae of Artemia salina, 
which have been suggested as a model organism in toxicity 
assessment of NPs.200 No toxicity on Artemia larvae was 
demonstrated by SeNPs up to 100 μg⋅mL−1.
Furthermore, the method of extraction of biogenic 
NPs substantially affects the toxicity of SeNPs. Sonkusre 
et al34 reported a novel method for the extraction and puri-
fication of intracellular SeNPs from the Gram-positive 
bacteria B. licheniformis JS2. These neutral-charged, 
non-agglomerating NPs at a very low concentration as low 
as 2 μg Se⋅mL−1 were efficacious in inhibiting proliferation 
and excellent in inducing caspase-independent necrosis 
of human prostate adenocarcinoma cells (PC3) without 
causing any significant toxicity to human peripheral blood 
mononuclear cells.
Conclusion
Selenium is an important essential element that interferes 
through selenoproteins in many physiological processes of 
the organism and affects the production and reproductive 
properties. By providing adequate supply of selenium in the 
diet, it is possible to effectively prevent health problems from 
its deficiency. Due to its high bioavailability, low toxicity and 
affordability, selenium in its nanoform appears to be the most 
appropriate for supplementation, especially in ruminants, in 
which traditionally used selenium compounds exhibit very 
low absorption in the digestive tract.
Future perspective is the possibility of global applica-
tion of nanoscale selenium in nutrition as well as in clinical 
medicine. The development of new NP systems for the 
transport of selenium in the organism, with the possibility 
of modifying physicochemical properties of the particles, 
greater stability in the gastrointestinal tract, and allowing 
controlled release of selenium, offers a significant dietary 
and therapeutic potential. Although there are currently 
some concerns about the use of SeNPs for therapeutic 
purposes, many scientific studies suggested that many of 
these generally prevailing doubts have not been confirmed. 
However, it is still necessary to carry out further preclinical 
studies in animal models.
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